You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Antitumor drugs

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myocardial Injury and Intestinal Flora Changes Associated With

Recruiting
  • Cancer Therapy-related Cardiovascular Toxicity
  • Antitumor drugs
  • Beijing, China
    Zhenyu Tian
Feb 6, 2023

Heart Function in Breast Cancer Patients Using Trastuzumab

Recruiting
  • Cardiotoxicity
  • +3 more
  • Peking, Beijing, China
    Peking University Third Hospital
Jul 4, 2021

Trastuzumab-related Cardiotoxicity in Breast Cancer Patients

Recruiting
  • Cardiac Toxicity
  • +2 more
  • Peking, Beijing, China
    Peking University Third Hospital
Jul 4, 2021

Diarrhea Caused by Antitumor Drugs Trial in Tianjin (Traditional Chinese Medicine)

Recruiting
  • Diarrhea Caused by Antitumor Drugs
  • Traditional Chinese Medicine
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute and Hospital
Aug 3, 2021

Advanced Cancer, Ovarian Cancer, Lung Cancer Trial in United States (Dose escalation: COM902 monotherapy., Evaluation of

Recruiting
  • Advanced Cancer
  • +6 more
  • Dose escalation: COM902 monotherapy.
  • +3 more
  • Grand Rapids, Michigan
  • +5 more
Aug 8, 2022

Advanced Solid Tumors Trial in Worldwide (BGB-30813, Tislelizumab)

Not yet recruiting
  • Advanced Solid Tumors
  • Hackensack, New Jersey
  • +10 more
Jun 6, 2023

Lung Cancer, Organoid, NSCLC Trial in Wuxi (Antitumor therapy guided by organoid drug sensitivity test)

Recruiting
  • Lung Cancer
  • +2 more
  • Antitumor therapy guided by organoid drug sensitivity test
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Feb 2, 2023

Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)

Recruiting
  • Endometrial Neoplasms
  • +3 more
  • COM701 in combination with BMS-986207 and nivolumab.
  • Chicago, Illinois
  • +8 more
Aug 8, 2022

Hand-foot Syndrome Trial in Guangzhou (Mecobalamin 5 MG Disintegrating Oral Tablet, )

Not yet recruiting
  • Hand-foot Syndrome
  • Mecobalamin 5 MG Disintegrating Oral Tablet
  • placebo
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Dec 20, 2021

General Anesthesia and PECS Block Methods on Blood Counts in

Completed
  • Breast Cancer
  • general anesthesia
  • peripheral nerve blocks
  • Ankara, Yenimahalle, Turkey
    Dr.Abdurrahman Yurtaslan Ankara Oncology Train and Research Hosp
Nov 21, 2023

Biliary Tract Cancer Trial in Goyang-si, Seoul (SMT-NK inj.+Pembrolizumab, Pembrolizumab)

Recruiting
  • Biliary Tract Cancer
  • Goyang-si, Gyeonggi-do, Korea, Republic of
  • +2 more
Jun 28, 2022

Metastatic Esophageal, Gastric Cancer, Metastatic Head and Neck Carcinoma Trial in Houston (LVGN3616 + LVGN6051 +

Recruiting
  • Metastatic Esophageal
  • +7 more
  • LVGN3616 + LVGN6051 + Nab-Paclitaxel
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Solid Tumor, Adult Trial in Richmond (Neratinib, Divalproex Sodium)

Recruiting
  • Solid Tumor, Adult
  • Richmond, Virginia
    Virginia Commonwealth University Massey Cancer Center
Mar 2, 2022

Extensive-stage Small-cell Lung Cancer Trial in Haikou (Trilaciclib)

Active, not recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Haikou, Hainan, China
    Hainan General Hospital
Jun 13, 2022

Drug-Induced Acute Liver Injury Trial in Tianjin (Bicyclol tablets)

Recruiting
  • Drug-Induced Acute Liver Injury
  • Bicyclol tablets
  • Tianjin, Tianjin, China
    Tianjin Medical University Cancer Institute & Hospital
Feb 2, 2023

Adult Solid Tumor Trial in Rochester (Erlotinib Hydrochloride, Irinotecan Hydrochloride)

Active, not recruiting
  • Adult Solid Neoplasm
  • Erlotinib Hydrochloride
  • Irinotecan Hydrochloride
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 12, 2023

Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study

Not yet recruiting
  • Breast Carcinoma
  • Biospecimen Collection
  • Questionnaire Administration
  • Scottsdale, Arizona
  • +2 more
Jan 18, 2023

Metastatic Colorectal Cancer Trial in Fuzhou (Thalidomide, TAS-102)

Recruiting
  • Metastatic Colorectal Cancer
  • Fuzhou, Fujian, China
  • +5 more
Mar 4, 2022

Recurrent Neuroblastoma Trial in Germany (metronomic therapy)

Recruiting
  • Recurrent Neuroblastoma
  • metronomic therapy
  • Bonn, Germany
  • +7 more
Nov 3, 2022

Solid Tumor Trial in United States (CPO-100)

Recruiting
  • Solid Tumor
  • Los Angeles, California
  • +9 more
Dec 16, 2022

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)

Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Los Angeles, California
  • +9 more
Jun 27, 2023

NSCLC, EGF-R Positive NSCLC Trial in Wuxi (Parimparib, Chemotherapy drug, Targeted Therapy Agent)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • EGF-R Positive Non-Small Cell Lung Cancer
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Jan 30, 2023

Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

Active, not recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Tampa, Florida
  • +1 more
Jan 13, 2023

Advanced Solid Tumor, NSCLCs Trial in Houston (Adagrasib, Olaparib)

Not yet recruiting
  • Advanced Solid Tumor
  • Non-small Cell Lung Cancers
  • Houston, Texas
    M D Anderson Cancer Center
Nov 15, 2023

MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)

Not yet recruiting
  • MSS
  • Rectal Cancer
  • Sintilimab with Interleukin-2
  • (no location specified)
Nov 1, 2023